1163TiPACTIVITY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH OCTREOTIDE LAR AND METFORMIN IN PATIENTS WITH ADVANCED PANCREATIC WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS (PWDNETS): A SINGLE–CENTER, OPEN-LABEL, PHASE II, PROOF-OF-CONCEPT STUDY (METNET1 TRIAL)
De Braud, F.G.M., Pusceddu, S., Formisano, B., Consonni, P., Pacifici, M., Pulice, J., Concas, L., Festinese, F., Bregant, C., Martinetti, A., Buzzoni, R.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu345.32
Date:
September, 2014
File:
PDF, 64 KB
2014
File converter
More search results
More benefits 
